# Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

> clinical trial · VERIFIED · 2026-08-14

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Macular Degeneration

- Company: Hoffmann-La Roche
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT04567303

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
